• Users Online: 484
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Reader Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2019| January-June  | Volume 5 | Issue 1  
    Online since July 22, 2019

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
ORIGINAL ARTICLES
Oral ranitidine: A promising novel therapeutic option in molluscum contagiosum in children
Pooja Agarwal, Bhushan Madke, Priyanka Bodar
January-June 2019, 5(1):26-29
DOI:10.4103/ijdd.ijdd_41_18  
  3,687 184 -
REVIEW ARTICLE
Janus Kinase Inhibitors in Dermatology
Aditya Kumar Bubna
January-June 2019, 5(1):6-13
DOI:10.4103/ijdd.ijdd_38_18  
  2,773 383 -
EDITORIAL
Biologics in psoriasis: Indian experience
Shrichand G Parasramani, Jisha Pillai
January-June 2019, 5(1):1-5
DOI:10.4103/ijdd.ijdd_33_19  
  2,814 313 -
MANAGING A SIDE EFFECT
Managing a side effect: Cyclophosphamide-induced hemorrhagic cystitis
Bhavana Ravindra Doshi, Vijaya Veeranna Sajjan, BS Manjunathswamy
January-June 2019, 5(1):66-71
DOI:10.4103/ijdd.ijdd_31_19  
  1,359 162 -
CASE REPORTS
“PRIDE” Complex: A Report of Two Cases
Shashank Krishna Agrawal, Bhagyashree Babanrao Supekar, Vaishali Wankhade, Rajesh Pratap Singh
January-June 2019, 5(1):42-45
DOI:10.4103/ijdd.ijdd_8_19  
  1,294 81 -
ORIGINAL ARTICLES
A comparative study between topical adapalene (0.1%) versus a combination of topical adapalene (0.1%) and intense pulsed light therapy in the treatment of inflammatory and noninflammatory facial acne vulgaris: A split-face randomized controlled trial
Shah Karan, Jadhav Vikrant, Gugle Anil
January-June 2019, 5(1):19-25
DOI:10.4103/ijdd.ijdd_28_18  
  874 74 -
LETTERS TO EDITOR
Drug-induced Henoch-Schonlein purpura with severe gastrointestinal involvement
Nibedita Dixit, Chinmoy Raj, Debasmita Behera, Maitreyee Panda
January-June 2019, 5(1):46-48
DOI:10.4103/ijdd.ijdd_24_19  
  750 50 -
Potassium iodide: A prodigy in the treatment of subcutaneous zygomycosis
Peela Nalini, Seethalakshmi Ganga Vellaisamy, Navakumar Manickam, Kannan Gopalan
January-June 2019, 5(1):59-62
DOI:10.4103/ijdd.ijdd_10_19  
  693 66 -
BRIEF REPORT
Successful Treatment of Pyogenic Granuloma with Sclerotherapy
Neelima Bansal, Vasudha A Belgaumkar, Ravindranth B Chavan, Bhavana Ravindra Doshi
January-June 2019, 5(1):30-33
DOI:10.4103/ijdd.ijdd_6_19  
  701 55 -
ORIGINAL ARTICLES
Real-life efficacy and safety of secukinumab: A single-center, retrospective observational study with 52-week follow-up
Shekhar Neema, S Radhakrishnan, Sehdev Singh, Biju Vasudevan, Manas Chatterjee
January-June 2019, 5(1):14-18
DOI:10.4103/ijdd.ijdd_37_18  
  562 78 -
VIVA VOCE
Viva voce on apremilast
Uday S Khopkar, Kinjal Deepak Rambhia
January-June 2019, 5(1):63-65
DOI:10.4103/ijdd.ijdd_36_19  
  519 104 -
CASE REPORTS
Sorafenib-Induced Cutaneous Toxicities: Four Different Presentations
Pooja Bains, Saurabh Sharma
January-June 2019, 5(1):34-37
DOI:10.4103/ijdd.ijdd_36_18  
  542 39 -
LETTERS TO EDITOR
Drug-Induced Hypersensitivity Syndrome to Leflunomide
Dhanashree Santosh Bhide, Kiran Chartrabhuj Ardad, Jaismeen Kaur Arora
January-June 2019, 5(1):48-50
DOI:10.4103/ijdd.ijdd_22_19  
  391 34 -
Desloratadine induced headache: Are we noticing or missing it?
Harsimran Chawla, Mohammad Rafi, Chaitanya Namdeo, Chhaya Goyal
January-June 2019, 5(1):57-58
DOI:10.4103/ijdd.ijdd_18_19  
  340 24 -
A first case of late-onset imatinib mesylate-induced lichenoid drug eruption
Farhana I Khan, Girishkumar R Ambade, A G. Krishna Greeshma, Anand J Asia
January-June 2019, 5(1):51-54
DOI:10.4103/ijdd.ijdd_15_19  
  291 56 -
Delayed-onset serum sickness due to rituximab in pemphigus vulgaris
Ajay Deshpande
January-June 2019, 5(1):54-57
DOI:10.4103/ijdd.ijdd_5_19  
  303 42 -
WHAT’S IN NEWS
News from regulatory corner: Safety communication and recent drug approvals
Manasi Shirolikar
January-June 2019, 5(1):72-74
DOI:10.4103/ijdd.ijdd_28_19  
  285 50 -
CASE REPORTS
Thalidomide-induced leukocytoclastic vasculitis in leprosy
Vasudha Abhijit Belgaumkar, Pallavi Prataprao Patil, Ravindranath Brahmadeo Chavan, Prernaa R Suryataley
January-June 2019, 5(1):38-41
DOI:10.4103/ijdd.ijdd_14_19  
  294 39 -